Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forman

Showing results (361-370 of 372) with videos related to

Pageof 38
Sort By:
Contemporary Clinical Trials|December 25, 2017
Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS): Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatmentsM A W Hawkins, Janna Colaizzi, John Gunstad, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2019
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary CholangitisChristopher L Bowlus, Paul J Pockros, Andreas E Kremer, et al.
Journal of Lipid Research|August 5, 2003
FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbitsGuorong Xu, Hai Li, Lu-Xing Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Hepatology Communications|May 15, 2023
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot studyChristopher L Bowlus, Bertus Eksteen, Angela C Cheung, et al.
The Journal of Biological Chemistry|October 29, 2002
Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbitsGuorong Xu, Lu-Xing Pan, Hai Li, et al.
Journal of Lipid Research|January 17, 2002
Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbitsGuorong Xu, Lu-xing Pan, Sandra K Erickson, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 17, 2015
An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicineSara Nasser, Ahmet A Kurdolgu, Tyler Izatt, et al.
Molecular Cancer Therapeutics|June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream TeamPatricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Obesity (Silver Spring, Md.)|September 10, 2025
Toward Health Equity: A Workshop Report on the State of the Science of Obesity Interventions for AdultsLoneke T Blackman Carr, Jamy Ard, Carmen Byker Shanks, et al.
Pageof 38

Showing results (361-370 of 372) with videos related to

Sort By:
Pageof 38
Contemporary Clinical Trials|December 25, 2017
Cognitive and Self-regulatory Mechanisms of Obesity Study (COSMOS): Study protocol for a randomized controlled weight loss trial examining change in biomarkers, cognition, and self-regulation across two behavioral treatmentsM A W Hawkins, Janna Colaizzi, John Gunstad, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2019
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary CholangitisChristopher L Bowlus, Paul J Pockros, Andreas E Kremer, et al.
Journal of Lipid Research|August 5, 2003
FXR-mediated down-regulation of CYP7A1 dominates LXRalpha in long-term cholesterol-fed NZW rabbitsGuorong Xu, Hai Li, Lu-Xing Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Hepatology Communications|May 15, 2023
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot studyChristopher L Bowlus, Bertus Eksteen, Angela C Cheung, et al.
The Journal of Biological Chemistry|October 29, 2002
Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbitsGuorong Xu, Lu-Xing Pan, Hai Li, et al.
Journal of Lipid Research|January 17, 2002
Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbitsGuorong Xu, Lu-xing Pan, Sandra K Erickson, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 17, 2015
An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicineSara Nasser, Ahmet A Kurdolgu, Tyler Izatt, et al.
Molecular Cancer Therapeutics|June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream TeamPatricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Obesity (Silver Spring, Md.)|September 10, 2025
Toward Health Equity: A Workshop Report on the State of the Science of Obesity Interventions for AdultsLoneke T Blackman Carr, Jamy Ard, Carmen Byker Shanks, et al.
Pageof 38